Definitive Contract 75N91023C00006
Award Date 2/27/23
Potential Completion Date 6/26/24
Potential Value $355K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
GRANDVIEW, OH 43212, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
21
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- Columbus Nanoworks, Inc., a biotechnology research company specializing in nanomaterials development, has been awarded a $506,498 Small Business Innovation Research (SBIR) Phase I contract by the National Cancer Institute to develop quantum-based diagnostic technologies for inflammatory breast cancer. The contract is designated as a Total Small Business set-aside with firm fixed-price terms and a completion date of September 4, 2026. Work will be performed in Grandview, Ohio, with Columbus...
- This contract was awarded by the National Cancer Institute (NCI), a civilian agency, to the small business prime contractor Columbus Nanoworks, Inc. The $299,999 Firm Fixed Price contract is for the SBIR Phase I research and development of "Imaging for Cancer Immunotherapies-Moonshot," which is focused on advancing imaging technologies to support cancer immunotherapies. The work is being performed in Grandview, Ohio. Columbus Nanoworks is a for-profit biotechnology research company...
- This $2,049,554 firm fixed price definitive contract was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sentimetrix, Inc., a for-profit small business. The contract supports the SBIR Phase II effort for "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)," which was previously funded under a $454,907 SBIR Phase I contract in 2021. The PATHML effort aims to develop machine learning techniques to analyze human posture...
- This is a $340,334.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian federal agency, to Genomic Expression Inc., a woman-owned small business. The contract is for the EO 14042 SBIR TOPIC 425 PHASE I: POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML) research project, which is part of the Small Business Innovation Research (SBIR) program. The contract has a period of performance ending on February 27, 2024. As an SBIR Phase I award, this contract is focused on the...
- This $454,907 firm fixed price contract was awarded by the National Institutes of Health National Cancer Institute to Sentimetrix, Inc. for research under the SBIR Phase I topic "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)". The contract is associated with the Department of Health and Human Services' National Institutes of Health and Centers for Disease Control and Prevention SBIR solicitation seeking innovative solutions across cancer research, infectious diseases, public...
- This is a $1,250,000.00 Small Business Technology Transfer (STTR) Phase II contract awarded by the U.S. Air Force Research Laboratory (AFRL) to Columbus Nanoworks, Inc., a for-profit biotechnology research company, for the development of a nitrogen vacancy-biosensor platform for quantum-based single molecule detection and its use to detect micro ribonucleic acid (microRNA) and cortisol as human performance-based biomarkers. This firm-fixed-price purchase order contract has a completion date of...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
- This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to Quantum Mark, LLC, a woman-owned small business. The $749,995.54 cost-plus-fixed-fee contract was awarded under the Small Business Innovation Research (SBIR) Phase II program to develop software systems to facilitate the use of electronic data records in the collection of population-based cancer surveillance data. The contract has a period of performance through June 29, 2012 and was set aside for...
- <p>The National Cancer Institute (NCI) awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Nanoscale Corporation for the development of a rapid in vitro screening assay to detect cancer biomarkers in urine and blood. The $150,000.00 firm-fixed-price contract has a completion date of May 2, 2013. This SBIR contract is part of the NCI's efforts to support small businesses in the development of innovative cancer-related technologies.</p>
- <p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>